Moxidectin Market

Moxidectin Market Size, Share & Industry Analysis, By Source (Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers) By End-User (Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Moxidectin market is projected to grow at a CAGR of 6.2% from 2025 to 2035, driven by increasing global efforts to combat neglected tropical diseases and its expanding use in veterinary parasitology. Moxidectin is a macrocyclic lactone endectocide structurally related to ivermectin. It functions by binding to glutamate-gated chloride channels in invertebrate nerve and muscle cells, causing parasite paralysis and death. It is approved for the treatment of onchocerciasis (river blindness) in humans and is widely used in companion and livestock animals for internal and external parasite control.

In humans, Moxidectin is being positioned as a superior alternative to ivermectin due to its longer half-life and sustained activity, which may improve long-term parasite control and reduce reinfection rates. Its use is being promoted in mass drug administration (MDA) campaigns, particularly in Africa. In veterinary settings, Moxidectin is used to treat heartworms, mites, and gastrointestinal worms in cattle, sheep, dogs, and horses.

Regionally, Africa and parts of Latin America represent the largest demand centers for human use, particularly through public health programs targeting onchocerciasis. For veterinary use, North America and Europe dominate due to high pet ownership, advanced livestock care, and regulatory support for antiparasitic drugs. Meanwhile, Asia-Pacific is expected to grow rapidly, especially in animal health, due to intensifying livestock production and rising companion animal care in countries like China, India, and Australia.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Moxidectin
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Pharmaceutical Manufacturers (Branded & Generic)
    • Contract Manufacturing Organizations (CMOs)
    • Research-Grade Suppliers
  • Key End-Use Industries
    • Pharmaceutical Industry.
    • Hospitals & Clinics.
    • Research Institutions.
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Moxidectin?
Moxidectin is a macrocyclic lactone anthelmintic primarily used to treat parasitic infections such as onchocerciasis (river blindness) in humans and heartworm, mites, and gastrointestinal worms in animals. It works by disrupting neurotransmission in parasites, leading to paralysis and death. Moxidectin is structurally related to ivermectin but has a longer half-life and enhanced efficacy against certain parasite strains, making it particularly effective for long-term suppression of microfilariae in river blindness.
What is the market growth of Moxidectin?
The global Moxidectin market is expected to grow at a CAGR of 5.8% from 2025 to 2035, rising from approximately USD 320 million in 2025 to USD 565 million by 2035. Growth is driven by increased adoption in human antiparasitic programs, especially in Africa, and expanding use in veterinary medicine, including livestock, companion animals, and aquaculture.
What are the drivers of the Moxidectin market?
Key drivers include rising global parasitic disease burden, WHO endorsement for onchocerciasis control, and superior pharmacokinetics compared to older anthelmintics. Moxidectin is increasingly used in mass drug administration (MDA) programs for neglected tropical diseases (NTDs), and its broad-spectrum activity makes it valuable for integrated parasite management in animals. The shift away from ivermectin resistance in veterinary applications is also boosting demand.
Who are the key players operating in the Moxidectin market?
Major producers include Boehringer Ingelheim (through its animal health division), Elanco, Zoetis, and Virbac. In the human health segment, Medicines Development for Global Health (MDGH) has received FDA approval for the treatment of river blindness. Generic manufacturers in India and China are also emerging players for both API supply and finished dose formulations.
Which region will exhibit the fastest growth in the Moxidectin market?
Sub-Saharan Africa is expected to lead human-use growth due to the high prevalence of onchocerciasis and strong NGO/governmental support for elimination campaigns. In the veterinary segment, Latin America and Asia-Pacific are forecast to grow rapidly, fueled by expanding livestock populations, companion animal health investments, and increased awareness of parasite control.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.